SeaSpine Holdings

SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CARLSBAD, Calif., Dec. 27, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the placement of its 100th 7D FLASH™ Navigation System globally. The 7D FLASH™ Navigation System uses visible light to create a three-dimensional image for surgical navigation in just seconds, which is expected to result in shorter and more efficient spinal procedures with less radiation exposure. It is the only marketed image-guidance system that utilizes novel and proprietary camera-based technology, coupled with machine-vision algorithms, to eliminate the long-standing frustrations with legacy surgical navigation platforms.

SeaSpine Announces 100th Placement of 7D FLASH™ Navigation System

SeaSpine Holdings Corporation has a deal to combine with OFIX, yet, there are still some minor uncertainties. Our dive found that the pediatrics market could be an interesting segment with strong economics.

Checking If The Orthofix Merger Makes Sense For SeaSpine

Orthofix International

NEW ORLEANS--( BUSINESS WIRE )--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of SeaSpine Holdings Corporation (NasdaqGS: SPNE) with Orthofix Medical Inc. (NasdaqGS: OFIX). Under the terms of the proposed transaction, shareholders of SeaSpine will receive only 0.4163 shares of Orthofix for each share of SeaSpine that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

SEASPINE HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of SeaSpine Holdings Corporation - SPNE

LEWISVILLE, Texas & CARLSBAD, Calif.--( BUSINESS WIRE )--Orthofix (NASDAQ: OFIX), a global medical device company with a spine and orthopedics focus, and SeaSpine (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that John Bostjancic will serve as Chief Financial Officer (CFO) for the new combined company, effective upon the completion of their pending merger.

Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing

First Eagle Alternative Capital BDC Inc

NEW YORK , Nov. 2, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: First Eagle Alternative Capital BDC, Inc. (NASDAQ: FCRD)'s  sale to Crescent Capital BDC, Inc. If you are a First Eagle shareholder, click here to learn more about your rights and options . SeaSpine Holdings Corporation (NASDAQ: SPNE)'s  sale to Orthofix Medical Inc. for 0.4163 shares of Orthofix common stock for each share of SeaSpine common stock.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FCRD, SPNE, OFIX

SeaSpine Holdings Corp (NASDAQ:SPNE ) Q3 2022 Earnings Conference Call November 1, 2022 4:30 PM ET Company Participants Greg Chodaczek - IR Keith Valentine - President, CEO & Director John Bostjancic - SVP, CFO, COO & Treasurer Conference Call Participants Ryan Zimmerman - BTIG Kyle Rose - Canaccord Genuity Samuel Brodovsky - BTIG Jeffrey Cohen - Ladenburg Thalmann & Co. Ross Osborn - Cantor Fitzgerald Jason Wittes - Loop Capital Markets Operator Welcome to SeaSpine's Third Quarter Financial Results Conference Call. [Operator Instructions].

SeaSpine Holdings Corp (SPNE) Q3 2022 Earnings Call Transcript

SeaSpine (SPNE) delivered earnings and revenue surprises of -40% and 0.34%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

SeaSpine Holdings (SPNE) Reports Q3 Loss, Tops Revenue Estimates

CARLSBAD, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the third quarter of 2022.

SeaSpine Announces 45% Revenue Growth and Record Revenue for Third Quarter 2022

CARLSBAD, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Mariner® MIS Wayfinder System.

SeaSpine Announces Full Commercial Launch of the Mariner MIS Wayfinder System

CARLSBAD, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release third quarter financial results after the close of trading on Tuesday, November 1, 2022. Members of the Company's management team will host a corresponding conference call and webcast beginning at 1:30 pm PT / 4:30 pm ET.

SeaSpine to Report Third Quarter 2022 Financial Results on November 1, 2022

SeaSpine (SPNE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SeaSpine Holdings (SPNE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

CARLSBAD, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the 7D FLASH™ Navigation System Percutaneous Spine Module. The release of the Percutaneous Module represents a new application and increased functionality for its 7D FLASH Navigation System, which now allows SeaSpine to further penetrate the minimally invasive spine surgery market, which SeaSpine estimates at approximately $4 billion worldwide.

SeaSpine Announces Full Commercial Launch of the 7D FLASH™ Navigation System Percutaneous Spine Module for Minimally Invasive Surgery

NEW YORK , Oct. 14, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX) in connection with the proposed acquisition of the Company by SeaSpine Holdings Corporation ("SeaSpine") (NASDAQ: SPNE).  Under the terms of the merger agreement, the Company's shareholders will receive 0.4163 shares of SeaSpine common stock for each Orthofix share owned, representing implied per-share merger consideration of approximately $2.44 based upon SeaSpine' October 13, 2022 closing price of $5.86.

SHAREHOLDER ALERT: Weiss Law Investigates Orthofix Medical Inc.

Wilmington, Delaware--(Newsfile Corp. - October 12, 2022) - Rigrodsky Law, P.A. is investigating SeaSpine Holdings Corporation ("SeaSpine") (NASDAQ: SPNE) regarding possible breaches of fiduciary duties and other violations of law related to SeaSpine's agreement to be acquired by Orthofix Medical Inc.To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-seaspine-holdings-corporation.To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email info@rl-legal.com.Rigrodsky Law, P.A.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating SeaSpine Holdings Corporation Buyout

MILWAUKEE , Oct. 11, 2022 /PRNewswire/ -- Ademi LLP is investigating SeaSpine (NASDAQ: SPNE) for possible breaches of fiduciary duty and other violations of law in its transaction with Orthofix.  Click here to learn how to join the action: https://www.ademilaw.com/case/seaspine-holdings-corporation or call Guri Ademi toll-free at 866-264-3995.

Shareholder Alert: Ademi LLP investigates whether SeaSpine Holdings Corporation has obtained a Fair Price in its transaction with Orthofix

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of SeaSpine Holdings Corporation (NASDAQ: SPNE) to Orthofix Medical Inc. for 0.4163 shares of Orthofix common stock for each share of SeaSpine common stock is fair to SeaSpine shareholders. Following the close of the transaction, SeaSpine shareholders will own approximately 43.5% of the combined company. Halper Sadeh encourages SeaSpine shareholders to click here to learn more about their

SPNE STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of SeaSpine Holdings Corporation Is Fair to Shareholders

CARLSBAD, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the third quarter of 2022.

SeaSpine Announces 44% to 45% Preliminary Revenue Growth for Third Quarter 2022 and Raises Full Year 2022 Revenue Guidance

LEWISVILLE, Texas & CARLSBAD, Calif.--(BUSINESS WIRE)--Orthofix (NASDAQ: OFIX), a global medical device company with a spine and orthopedics focus, and SeaSpine (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced they have entered into a definitive agreement to combine in an all-stock merger of equals. The combined company, to be named prior to the transaction's closing, will be a leading global spine and ortho

Orthofix and SeaSpine to Combine in Merger of Equals to Create Leading Global Spine and Orthopedics Company

CARLSBAD, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the company will present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29, 2022 beginning at 12:00 p.m. ET.

SeaSpine to Present at the 2022 Ladenburg Thalmann Healthcare Conference

CARLSBAD, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the WaveForm TA (TLIF Articulating) Interbody System.

SeaSpine Announces Full Commercial Launch of the WaveForm® TA (TLIF Articulating) Interbody System

CARLSBAD, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022 at 9:30 a.m. Pacific time / 12:30 p.m. Eastern time.

SeaSpine to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

SeaSpine Holdings Corp (NASDAQ:SPNE ) Q2 2022 Earnings Conference Call August 2, 2022 4:30 PM ET Company Participants Leigh Salvo - Gilmartin Group Keith Valentine - President, CEO & Director John Bostjancic - SVP, CFO, COO & Treasurer Conference Call Participants Kyle Rose - Canaccord Genuity Ryan Zimmerman - BTIG Richard Newitter - Truist Securities Jeffrey Cohen - Ladenburg Thalmann & Co. Ross Osborn - Cantor Fitzgerald & Co. Operator Thank you for standing by, and welcome to the SeaSpine's 2022 Second Quarter Financial Results Conference Call. [Operator Instructions].

SeaSpine Holdings Corp (SPNE) CEO Keith Valentine on Q2 2022 Results - Earnings Call Transcript

SeaSpine (SPNE) delivered earnings and revenue surprises of -8.57% and 3.64%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

SeaSpine Holdings (SPNE) Reports Q2 Loss, Tops Revenue Estimates

CARLSBAD, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today second quarter financial results for the three-months ended June 30, 2022.

SeaSpine Reports 19% Revenue Growth and Record Quarterly Revenue for Second Quarter 2022 and Raises Full Year 2022 Revenue Guidance

CARLSBAD, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company will present at the Canaccord Genuity 42nd Annual Global Growth Conference on August 10, 2022 beginning at 8:00 AM ET.

News for SeaSpine Holdings Stock (SPNE)